Establishment of human trophoblast stem cells from term placentas for therapeutic and clinical applications
Publish time: 2021-11-17 00:00:00
Establishment of human trophoblast stem cells from term placentas for therapeutic and clinical applications
Docket Number
11A-1090817
IP Status
USP
Abstract
Specific gene is key factors in regulation of the stemness and differentiation of TSCs.This invention disclose Cell form placenta of a full-term pregnancy.It is collected for establishment of TSTerm cells.We shut down specific gene expression by hypoxia or CRISPR/Cas9and are able to establish TSTerm cells. The cell capable of differentiating into specific trophoblast lineages. With the advance in the field of different adult stem cells.
Technological Advantages
- Establishment of TSTerm cells from term trophoblast cells
- Gene knockout in TSTerm cells by CRISPR/Cas9 system
Applications of Technology
- Establishment of individual TSTerm cells for autologous cell therapy or personalized medical treatments
- Generation of specific cell lineages from TSTerm cells for clinical therapies
- TSTerm cells as a research model system for pregnancy disorders
Inventor
Hung-wen Chen, Liang-Jie Wang, Chie-Pein Chen
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Establishment of human trophoblast stem cells from term placentas for therapeutic and clinical applications